Ensemble machine learning algorithm for anti-VEGF treatment efficacy prediction in diabetic macular edema.
Journal:
BMC ophthalmology
Published Date:
Jul 1, 2025
Abstract
BACKGROUND: Diabetic macular edema (DME) is a leading cause of vision loss in diabetes, with variable responses to anti-vascular endothelial growth factor (anti-VEGF) therapy in DME patients. Current diagnosis relies on optical coherence tomography (OCT) imaging, but manual interpretation is limited. This study aims to integrate 3D-OCT features and clinical variables to develop machine learning (ML) models for predicting anti-VEGF treatment outcomes.
Authors
Keywords
No keywords available for this article.